These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37543492)

  • 1. Not all tumour necrosis is granular necrosis.
    Samaratunga H; Egevad L; Delahunt B
    Pathology; 2023 Oct; 55(6):903-904. PubMed ID: 37543492
    [No Abstract]   [Full Text] [Related]  

  • 2. Not all tumour necrosis is granular necrosis: authors' response.
    Fuchs TL; Chou A; Ahadi M; Sheen A; Sioson L; Mittal A; Samra J; Gill AJ
    Pathology; 2023 Oct; 55(6):904-906. PubMed ID: 37544876
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour necrosis factor-alpha upregulates transferrin receptors in K 562 cells.
    Nezu M; Iwagaki H; Aoki H; Tanaka N; Orita K
    J Int Med Res; 1994; 22(3):145-52. PubMed ID: 8088421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
    de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
    Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.
    Hassan C; Ierardi E; Burattini O; De Francesco V; Zullo A; Stoppino G; Panella C; Morini S
    Dig Liver Dis; 2007 Sep; 39(9):811-7. PubMed ID: 17652038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia.
    Turhan L; Batmaz S; Kocbiyik S; Soygur AH
    Nord J Psychiatry; 2016 Jul; 70(5):342-50. PubMed ID: 26754110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity.
    Seynhaeve AL; de Wilt JH; van Tiel ST; Eggermont AM; ten Hagen TL
    Br J Cancer; 2002 Apr; 86(7):1174-9. PubMed ID: 11953868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha as a tumour promoter.
    Szlosarek P; Charles KA; Balkwill FR
    Eur J Cancer; 2006 Apr; 42(6):745-50. PubMed ID: 16517151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of enhanced responsiveness of human articular chondrocytes to extracellular ATP by tumour necrosis factor-alpha.
    Leong WS; Russell RG; Caswell AM
    Clin Sci (Lond); 1993 Nov; 85(5):569-75. PubMed ID: 8287645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha.
    Comini L; Bachetti T; Agnoletti L; Gaia G; Curello S; Milanesi B; Volterrani M; Parrinello G; Ceconi C; Giordano A; Corti A; Ferrari R
    Eur Heart J; 1999 Oct; 20(20):1503-13. PubMed ID: 10493849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing.
    Mohler KM; Sleath PR; Fitzner JN; Cerretti DP; Alderson M; Kerwar SS; Torrance DS; Otten-Evans C; Greenstreet T; Weerawarna K
    Nature; 1994 Jul; 370(6486):218-20. PubMed ID: 8028669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrotide protects endothelial cells, but not L929 tumour cells, from tumour necrosis factor-alpha-mediated cytotoxicity.
    Schröder H
    J Pharm Pharmacol; 1995 Mar; 47(3):250-2. PubMed ID: 7602491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Anti-tumour Necrosis Factor Alpha Agents: A Systematic Review and Meta-analysis.
    Yang C; Huang J; Huang X; Huang S; Cheng J; Liao W; Chen X; Wang X; Dai S
    J Crohns Colitis; 2018 Aug; 12(9):1042-1052. PubMed ID: 29762681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor alpha and cellular proliferation in primary biliary cirrhosis.
    Floreani A; Infantolino D; Biasin R; Della Rovere GR; Biagini MR; Melis A; Chiaramonte M
    Ital J Gastroenterol Hepatol; 1999; 31(1):56-60. PubMed ID: 10091104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tumour necrosis factor-α and its receptors in Hodgkin lymphoma.
    Nakayama S; Yokote T; Tsuji M; Akioka T; Miyoshi T; Hirata Y; Hiraoka N; Iwaki K; Takayama A; Nishiwaki U; Masuda Y; Hanafusa T
    Br J Haematol; 2014 Nov; 167(4):574-7. PubMed ID: 25039986
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease.
    Nielsen OH; Brynskov J; Bendtzen K
    Dan Med Bull; 1993 Apr; 40(2):247-9. PubMed ID: 8495600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granular cell tumour in a patient with Crohn's disease treated with infliximab: coincidence or causal relationship?
    Papamichael K; Archavlis E; Lariou C; Tsigka A; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):857-9. PubMed ID: 22475791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma.
    Yoshida N; Ikemoto S; Narita K; Sugimura K; Wada S; Yasumoto R; Kishimoto T; Nakatani T
    Br J Cancer; 2002 May; 86(9):1396-400. PubMed ID: 11986770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for whole body production of tumour necrosis factor-alpha in experimental endotoxaemia in healthy subjects.
    Koopmans R; Hoek FJ; van Deventer SJ; van der Poll T
    Clin Sci (Lond); 1994 Oct; 87(4):459-65. PubMed ID: 7835000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
    Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.